This rally is just the start…
Don’t tell the fear mongers on Wall Street or in Washington D.C., but there’s an incredible rally afoot.
No, I’m not talking about the performance of stocks in the Dow Jones Industrial Average. Nor am I referring to the S&P 500. Although, over the last couple of months, these two broad measures of stock market performance are both up around 35%.
I’m also not talking about thinly traded penny stocks that rallied from $0.02 to $0.06 for a 300% return on very little volume.
These performances aren’t bad, but they pale in comparison to what I’m seeing.
The sector I’m looking at comprises real companies growing revenues at over 100% per year despite a near-total shutdown in the economy.
With the stocks of these companies doubling on average, this isn’t your typical defensive sector – unless defense means scoring all the points.
The Cannabis Rally
The sector is cannabis, of course.
Based on the performance of our proprietary NICI 50 index, the top 50 cannabis companies by market capitalization have returned 151% since stock market lows were put in on March 18. That’s over four times what you could have made with something that tracks the Dow or S&P 500.
And it’s no surprise given the continued surge in cannabis sales.
It’s now up over 240%.
But the remarkable returns for these, and many other cannabis stocks we’ve witnessed over the last two months, is just the start of the incredible profits to be made by owning the top performers in this fast-growing sector.
By the end of the year, I fully expect the stocks of the best-run companies to surge another 5X or even 10X higher than they are right now.
So, for those of you still on the sidelines, you haven’t missed a thing – but you could if you don’t act soon.
To help you get started, I’ve assembled the Cannabis Moonshot Portfolio.
These are the companies not only posting incredible sales growth, but the ones that are led by high-quality management teams that have a proven ability to continually boost shareholder value.
The Moonshot Members
At the top of the list is a company that dominates the market of a medical-only state. It’s so well run that 76% of every dollar it earns yields value-added profit for shareholders.
Another leading grower with decades of experience operating mega-scale greenhouses can cultivate cannabis so efficiently that every $1 of cannabis sold only costs them $0.25.
And yet another company with the biggest lead in cannabis biotech has boosted sales of its leading product 3,276% over the last year, with another doubling expected over the next 12 months. The billions of dollars in value-added profits in store for this company will send its stock price to the moon.
All told, my Cannabis Moonshot Portfolio has 10 cannabis stocks that you need to consider owning right now – and many can still be had for under $10 a share.
But not for long.
Don Yocham, CFA
Executive Director, National Institute for Cannabis Investors
20 responses to “10 Stocks Under $10 to Put You on the Path to Life-Changing Wealth”
June 13 2020